Research Article
BibTex RIS Cite

The time interval between the hCG trigger and the oocyte pickup on IVF outcomes in patients with decreased ovarian reserve and poor prognosis

Year 2025, Volume: 11 Issue: 2, 404 - 411, 04.03.2025
https://doi.org/10.18621/eurj.1637474

Abstract

Objectives: This study aimed to evaluate the effect of varying intervals between human chorionic gonadotropin (hCG) administration and oocyte pickup (OPU) at 34, 35, and 36 hours on in vitro fertilization (IVF) outcomes and embryo development in patients with diminished ovarian reserve (DOR).

Methods: This retrospective cohort study utilised the Istanbul Memorial Şişli Hospital, assisted reproductive technology (ART) and Reproductive Genetics Center databases from January 2017 to March 2024. The study included women undergoing ART cycles with DOR, as defined by the Bologna criteria, and follicle-stimulating hormone (FSH) levels exceeding 12 IU/L on day 2 of menstruation. Nine hundred and forty-nine ovarian stimulation cycles were analysed using the gonadotropin-releasing hormone antagonist protocol and triggered by recombinant hCG (r-hCG). The cycles were divided into three groups based on the time interval between r-hCG injection and OPU at 34, 35, and 36 hours. Demographic characteristics, ovarian stimulation parameters, embryological outcomes, and pregnancy results were compared across these groups.

Results: The 36-hour OPU group demonstrated the highest fertilization, best embryological outcomes, including the highest blastocyst formation rate (14.95%) compared to the 34-hour (14.23%) and 35-hour (12.43%) groups (P=0.025). The 36-hour group also had the highest proportion of day 5–6 embryo transfers (33.8%, P=0.001). However, there were no significant differences in pregnancy outcomes.

Conclusions: In DOR patients, extending the OPU interval to 36 hours with hCG triggering showed higher fertilization rates and better embryo development than 34 and 35 hours. However, it did not affect pregnancy outcomes.

Ethical Statement

The study was approved by Memorial Şişli Hospital Ethics Committee (Decision date and no: 29.04.2024/002).

References

  • 1. Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L; ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26(7):1616-1624. doi: 10.1093/humrep/der092.
  • 2. Xie J, Xu X, Liu S. Intercellular communication in the cumulus-oocyte complex during folliculogenesis: A review. Front Cell Dev Biol. 2023;11:1087612. doi: 10.3389/fcell.2023.1087612.
  • 3. Gan R, Huang X, Zhao J, Zhang Q, Huang C, Li Y. Time interval between hCG administration and oocyte retrieval and ART outcomes: an updated systematic review and meta-analysis. Reprod Biol Endocrinol. 2023;21(1):61. doi: 10.1186/s12958-023-01110-9.
  • 4. Cakmak H, Fujimoto VY, Zamah AM, et al. Metaphase II (MII) oocytes obtained at different time points in the same in vitro fertilization cycle. J Assist Reprod Genet. 2012;29(11):1203-1205. doi: 10.1007/s10815-012-9852-5.
  • 5. Takahashi T, Igarashi H, Amita M, Hara S, Matsuo K, Kurachi H. Molecular mechanism of poor embryo development in postovulatory aged oocytes: mini review. J Obstet Gynaecol Res. 2013;39(10):1431-1439. doi: 10.1111/jog.12111.
  • 6. Hsu A, Arny M, Knee AB, et al. Antral follicle count in clinical practice: analyzing clinical relevance. Fertil Steril. 2011;95(2):474-479. doi: 10.1016/j.fertnstert.2010.03.023.
  • 7. Bosch E, Labarta E, Zuzuarregui J, Iliodromiti S, Nelson SM. Prediction of ovarian response using the automated Elecsys anti-Müllerian hormone assay in gonadotrophin-releasing hormone antagonist cycles. Reprod Biomed Online. 2023;46(2):295-301. doi: 10.1016/j.rbmo.2022.10.012.
  • 8. Wang W, Zhang XH, Wang WH, et al The time interval between hCG priming and oocyte retrieval in ART program: a meta-analysis. J Assist Reprod Genet. 2011;28(10):901-910. doi: 10.1007/s10815-011-9613-x.
  • 9. Garor R, Shufaro Y, Kotler N, et al. Prolonging oocyte in vitro culture and handling time does not compensate for a shorter interval from human chorionic gonadotropin administration to oocyte pickup. Fertil Steril. 2015;103(1):72-75. doi: 10.1016/j.fertnstert.2014.09.022.
  • 10. Shen X, Long H, Guo W, et al. Optimal Ovulation Trigger-Oocyte Pickup Interval in Progestin-Primed Ovarian Stimulation Protocol: A Retrospective Study Using Propensity Score Matching. Front Endocrinol (Lausanne). 2019;10:694. doi: 10.3389/fendo.2019.00694.
  • 11. Skvirsky S, Blais I, Lahav-Baratz S, Koifman M, Wiener-Megnazi Z, Dirnfeld M. Time interval between hCG administration and oocyte pick up: analysis of oocyte maturation, embryonic morphology, morphokinetics, and IVF outcome. CEOG. 2021;48(2):402-409. doi: 10.31083/j.ceog.2021.02.2284
  • 12. Shen X, Long H, Guo W, et al. The ovulation trigger-OPU time interval of different ovarian protocols in ART: a retrospective study. Arch Gynecol Obstet. 2020;302(2):519-527. doi: 10.1007/s00404-020-05568-5.
  • 13. Weiss A, Neril R, Geslevich J, et al Lag time from ovulation trigger to oocyte aspiration and oocyte maturity in assisted reproductive technology cycles: a retrospective study. Fertil Steril. 2014;102(2):419-23. doi: 10.1016/j.fertnstert.2014.04.041.
  • 14. Nargund G, Reid F, Parsons J. Human chorionic gonadotropin-to-oocyte collection interval in a superovulation IVF program. A prospective study. J Assist Reprod Genet. 2001;18(2):87-90. doi: 10.1023/a:1026530624575.
  • 15. Bosdou JK, Kolibianakis EM, Venetis CA, et al. Is the time interval between HCG administration and oocyte retrieval associated with oocyte retrieval rate? Reprod Biomed Online. 2015;31(5):625-632. doi: 10.1016/j.rbmo.2015.08.005.
  • 16. Ranit H, Shmuel H, Ahlad A, et al. Is there a preferred time interval between gonadotropin-releasing hormone (GnRH) agonist trigger and oocyte retrieval in GnRH antagonist cycles? A retrospective cohort of planned fertility preservation cycles. J Assist Reprod Genet. 2024;41(6):1531-1538. doi: 10.1007/s10815-024-03083-z.
  • 17. Choi MH, Cha SH, Park CW, et al. The effectiveness of earlier oocyte retrieval in the case of a premature luteinizing hormone surge on hCG day in in vitro fertilization-embryo transfer cycles. Clin Exp Reprod Med. 2013;40(2):90-94. doi: 10.5653/cerm.2013.40.2.90.
  • 18. Raziel A, Schachter M, Strassburger D, Kasterstein E, Ron-El R, Friedler S. In vivo maturation of oocytes by extending the interval between human chorionic gonadotropin administration and oocyte retrieval. Fertil Steril. 2006;86(3):583-587. doi: 10.1016/j.fertnstert.2006.02.091.
Year 2025, Volume: 11 Issue: 2, 404 - 411, 04.03.2025
https://doi.org/10.18621/eurj.1637474

Abstract

References

  • 1. Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L; ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26(7):1616-1624. doi: 10.1093/humrep/der092.
  • 2. Xie J, Xu X, Liu S. Intercellular communication in the cumulus-oocyte complex during folliculogenesis: A review. Front Cell Dev Biol. 2023;11:1087612. doi: 10.3389/fcell.2023.1087612.
  • 3. Gan R, Huang X, Zhao J, Zhang Q, Huang C, Li Y. Time interval between hCG administration and oocyte retrieval and ART outcomes: an updated systematic review and meta-analysis. Reprod Biol Endocrinol. 2023;21(1):61. doi: 10.1186/s12958-023-01110-9.
  • 4. Cakmak H, Fujimoto VY, Zamah AM, et al. Metaphase II (MII) oocytes obtained at different time points in the same in vitro fertilization cycle. J Assist Reprod Genet. 2012;29(11):1203-1205. doi: 10.1007/s10815-012-9852-5.
  • 5. Takahashi T, Igarashi H, Amita M, Hara S, Matsuo K, Kurachi H. Molecular mechanism of poor embryo development in postovulatory aged oocytes: mini review. J Obstet Gynaecol Res. 2013;39(10):1431-1439. doi: 10.1111/jog.12111.
  • 6. Hsu A, Arny M, Knee AB, et al. Antral follicle count in clinical practice: analyzing clinical relevance. Fertil Steril. 2011;95(2):474-479. doi: 10.1016/j.fertnstert.2010.03.023.
  • 7. Bosch E, Labarta E, Zuzuarregui J, Iliodromiti S, Nelson SM. Prediction of ovarian response using the automated Elecsys anti-Müllerian hormone assay in gonadotrophin-releasing hormone antagonist cycles. Reprod Biomed Online. 2023;46(2):295-301. doi: 10.1016/j.rbmo.2022.10.012.
  • 8. Wang W, Zhang XH, Wang WH, et al The time interval between hCG priming and oocyte retrieval in ART program: a meta-analysis. J Assist Reprod Genet. 2011;28(10):901-910. doi: 10.1007/s10815-011-9613-x.
  • 9. Garor R, Shufaro Y, Kotler N, et al. Prolonging oocyte in vitro culture and handling time does not compensate for a shorter interval from human chorionic gonadotropin administration to oocyte pickup. Fertil Steril. 2015;103(1):72-75. doi: 10.1016/j.fertnstert.2014.09.022.
  • 10. Shen X, Long H, Guo W, et al. Optimal Ovulation Trigger-Oocyte Pickup Interval in Progestin-Primed Ovarian Stimulation Protocol: A Retrospective Study Using Propensity Score Matching. Front Endocrinol (Lausanne). 2019;10:694. doi: 10.3389/fendo.2019.00694.
  • 11. Skvirsky S, Blais I, Lahav-Baratz S, Koifman M, Wiener-Megnazi Z, Dirnfeld M. Time interval between hCG administration and oocyte pick up: analysis of oocyte maturation, embryonic morphology, morphokinetics, and IVF outcome. CEOG. 2021;48(2):402-409. doi: 10.31083/j.ceog.2021.02.2284
  • 12. Shen X, Long H, Guo W, et al. The ovulation trigger-OPU time interval of different ovarian protocols in ART: a retrospective study. Arch Gynecol Obstet. 2020;302(2):519-527. doi: 10.1007/s00404-020-05568-5.
  • 13. Weiss A, Neril R, Geslevich J, et al Lag time from ovulation trigger to oocyte aspiration and oocyte maturity in assisted reproductive technology cycles: a retrospective study. Fertil Steril. 2014;102(2):419-23. doi: 10.1016/j.fertnstert.2014.04.041.
  • 14. Nargund G, Reid F, Parsons J. Human chorionic gonadotropin-to-oocyte collection interval in a superovulation IVF program. A prospective study. J Assist Reprod Genet. 2001;18(2):87-90. doi: 10.1023/a:1026530624575.
  • 15. Bosdou JK, Kolibianakis EM, Venetis CA, et al. Is the time interval between HCG administration and oocyte retrieval associated with oocyte retrieval rate? Reprod Biomed Online. 2015;31(5):625-632. doi: 10.1016/j.rbmo.2015.08.005.
  • 16. Ranit H, Shmuel H, Ahlad A, et al. Is there a preferred time interval between gonadotropin-releasing hormone (GnRH) agonist trigger and oocyte retrieval in GnRH antagonist cycles? A retrospective cohort of planned fertility preservation cycles. J Assist Reprod Genet. 2024;41(6):1531-1538. doi: 10.1007/s10815-024-03083-z.
  • 17. Choi MH, Cha SH, Park CW, et al. The effectiveness of earlier oocyte retrieval in the case of a premature luteinizing hormone surge on hCG day in in vitro fertilization-embryo transfer cycles. Clin Exp Reprod Med. 2013;40(2):90-94. doi: 10.5653/cerm.2013.40.2.90.
  • 18. Raziel A, Schachter M, Strassburger D, Kasterstein E, Ron-El R, Friedler S. In vivo maturation of oocytes by extending the interval between human chorionic gonadotropin administration and oocyte retrieval. Fertil Steril. 2006;86(3):583-587. doi: 10.1016/j.fertnstert.2006.02.091.
There are 18 citations in total.

Details

Primary Language English
Subjects Histology and Embryology
Journal Section Original Articles
Authors

Gönül Özer 0000-0003-2900-8623

İpek Nur Balın Düzgüner 0000-0003-1157-6817

Sevinç Özmen 0000-0002-5146-7300

Semra Kahraman 0000-0002-2686-4240

Early Pub Date February 27, 2025
Publication Date March 4, 2025
Submission Date February 12, 2025
Acceptance Date February 24, 2025
Published in Issue Year 2025 Volume: 11 Issue: 2

Cite

AMA Özer G, Balın Düzgüner İN, Özmen S, Kahraman S. The time interval between the hCG trigger and the oocyte pickup on IVF outcomes in patients with decreased ovarian reserve and poor prognosis. Eur Res J. March 2025;11(2):404-411. doi:10.18621/eurj.1637474

e-ISSN: 2149-3189 


The European Research Journal, hosted by Turkish JournalPark ACADEMIC, is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

by-nc-nd.png

2025